Concurrent Tissue and Circulating Tumor DNA Molecular Profiling to Detect Guideline-Based Targeted Mutations in a Multicancer Cohort
Wade T. Iams(Vanderbilt University Medical Center), Al B. Benson(Northwestern University), Rotem Ben‐Shachar(Tempus Labs (United States)), Adam J. Hockenberry(Tempus Labs (United States)), Massimo Cristofanilli(Cornell University), Kabir Manghnani(Tempus Labs (United States)), Halla Nimeiri(Tempus Labs (United States)), Matthew MacKay(Tempus Labs (United States)), Justin Guinney(Sage Bionetworks), Joshua Drews(Tempus Labs (United States))
Cited by 79
Related Papers
The Immune Landscape of Cancer
|Immunity|2018|6.2k
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.2k
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k
Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200
|Journal of Clinical Oncology|2007|2.3k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k